Catalyst
Slingshot members are tracking this event:
Celgene (CELG) 2018 data readout for Phase 3 OPTIMISM trial, testing POMALYST and IMNOVID in patients with relapsed refractory myeloma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CELG | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 06, 2018
Occurred Source:
http://ir.celgene.com/releasedetail.cfm?ReleaseID=1056455
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Pomalyst, Imnovid, Relapsed Multiple Myeloma, Optimism, Phase 3
